Companies /Healthcare

Tandem Diabetes Care Inc

NASDAQ: TNDM Medical Devices
$21.40
â–² $0.03 (+0.14%) today
Markets closed · 12:59am ET
Today · % change

Fundamentals

Market Cap
$1.5B
Profit Margin
-6.1%
Revenue (TTM)
$1.0B
EPS (TTM)
$-0.90
52-Week Range
$11 – $30
Street Target
$28.70

About Tandem Diabetes Care

Tandem Diabetes Care Inc specializes in innovative medical devices for diabetes management, primarily in the United States and internationally. The company's leading product, the t:slim X2 insulin delivery system, revolutionizes insulin management by integrating with continuous glucose monitoring systems for real-time data display. Additionally, Tandem offers the Tandem Mobi insulin pump, various single-use products like cartridges and infusion sets, and digital tools such as the Tandem Device Updater, Tandem Source data management platform, and Sugarmate app. Founded in 2006 and headquartered in San Diego, California, Tandem is dedicated to improving the lives of people with diabetes.

TNDM Coverage